logo
Regeneron's Cemdisiran and RNA Drug Show Promising Results in Rare Disease Trials, Boosting Stock Prospects

Regeneron’s Cemdisiran and RNA Drug Show Promising Results in Rare Disease Trials, Boosting Stock Prospects

Regeneron Pharmaceuticals has made significant breakthroughs in treating rare diseases, including a promising new therapy for generalized myasthenia gravis and a RNA drug for a rare autoimmune disease, with positive trial data expected to lead to FD…
2 minutes to read